Hepatitis B - HBsAg (Surface Antigen), by CMIA, Serum

Camp - Hepatitis B - HBsAg (Surface Antigen), by CMIA, Serum

Overview

The Hepatitis B Surface Antigen (HBsAg) by CMIA test is used to detect the presence of the Hepatitis B virus (HBV) in the blood. It helps diagnose an active Hepatitis B infection, whether acute or chronic. The Chemiluminescent Microparticle Immunoassay (CMIA) method provides highly accurate and sensitive results for early detection.

Why is this test done?

Your doctor may recommend this test to:

• Screen for Hepatitis B infection
• Diagnose acute or chronic Hepatitis B
• Evaluate individuals with symptoms of liver disease
• Screen pregnant women to prevent mother-to-child transmission
• Screen blood donors and healthcare workers
• Monitor people at high risk of Hepatitis B infection

Symptoms that may require testing

• Fatigue and weakness
• Loss of appetite
• Nausea and vomiting
• Fever
• Yellowing of the skin and eyes (Jaundice)
• Dark-colored urine
• Abdominal pain, especially in the upper right side
• Joint pain

Test Method

• Sample: Serum
• Method: CMIA (Chemiluminescent Microparticle Immunoassay)

Preparation

• No fasting is required.
• Inform your healthcare provider about any ongoing medications or recent Hepatitis B vaccination.

Understanding the Results

• Negative (Non-Reactive): No detectable Hepatitis B Surface Antigen. Usually indicates no current infection.
• Positive (Reactive): Indicates an active Hepatitis B infection. Additional tests such as HBV DNA, HBeAg, Anti-HBc, and liver function tests may be recommended for further evaluation.

Who should get tested?

• Individuals with symptoms of hepatitis
• Pregnant women
• Healthcare professionals
• People with multiple sexual partners
• Family members of Hepatitis B-positive individuals
• People receiving dialysis
• Individuals with weakened immune systems
• Blood and organ donors

Benefits of Early Detection

• Enables timely medical treatment
• Reduces the risk of liver cirrhosis and liver cancer
• Prevents transmission to others
• Helps monitor treatment and disease progression

MCC (Marketing Content Copy)

Protect Your Liver with Early Hepatitis B Screening!
The HBsAg by CMIA test offers accurate and reliable detection of active Hepatitis B infection. Early diagnosis helps ensure prompt treatment, protects your liver, and reduces the risk of spreading the infection. Get tested today for better health and peace of mind.